We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

77 hedge funds and large institutions have $221M invested in Utah Medical Products in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $210M → $221M (+$11M)

0.83% less ownership

Funds ownership: 72.83% → 72% (-0.83%)

9% less funds holding

Funds holding: 85 → 77 (-8)

10% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 29

89% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 9

Holders
77
Holders Change
-8
Holders Change %
-9.41%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
26
Reduced
29
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.27M
2
JP Morgan Chase
JP Morgan Chase
New York
+$1.22M
3
BlackRock
BlackRock
New York
+$626K
4
Renaissance Technologies
Renaissance Technologies
New York
+$590K
5
Goldman Sachs
Goldman Sachs
New York
+$514K

Top Sellers

Rank Fund Capital Flow
1
Natixis Advisors
Natixis Advisors
Massachusetts
-$1.08M
2
Millennium Management
Millennium Management
New York
-$907K
3
MAM
Martingale Asset Management
Massachusetts
-$863K
4
RIM
Ranger Investment Management
Texas
-$808K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$787K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMINC
26
Cardinal Capital Management Inc (North Carolina)
North Carolina
$827K +$20.4K +239 +2%
RJA
27
Raymond James & Associates
Florida
$645K -$61K -716 -9%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$644K -$8.53K -100 -1%
AIA
29
Affinity Investment Advisors
California
$618K – – –
WCM
30
Wedge Capital Management
North Carolina
$541K – – –
GC
31
Globeflex Capital
California
$534K – – –
Allianz Asset Management
32
Allianz Asset Management
Germany
$526K -$21.1K -247 -4%
SO
33
STRS Ohio
Ohio
$446K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$434K – – –
Arrowstreet Capital
35
Arrowstreet Capital
Massachusetts
$430K +$128K +1,500 +42%
AQR Capital Management
36
AQR Capital Management
Connecticut
$408K -$787K -9,234 -66%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$389K +$29.9K +351 +8%
AllianceBernstein
38
AllianceBernstein
Tennessee
$379K – – –
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$337K – – –
PIM
40
Penobscot Investment Management
Massachusetts
$337K – – –
SCP
41
Seizert Capital Partners
Michigan
$337K +$49.9K +585 +17%
FHB
42
First Hawaiian Bank
Hawaii
$331K – – –
Morgan Stanley
43
Morgan Stanley
New York
$299K +$183K +2,143 +153%
Deutsche Bank
44
Deutsche Bank
Germany
$297K +$55.4K +650 +23%
Invesco
45
Invesco
Georgia
$262K +$42.3K +496 +19%
PAM
46
Panagora Asset Management
Massachusetts
$260K +$200K +2,342 +315%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$248K – – –
ASN
48
Advisory Services Network
Georgia
$241K – – –
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$199K +$103K +1,214 +105%
OSAM
50
O'Shaughnessy Asset Management
Connecticut
$193K +$22.8K +268 +13%
1
2
3 4

UTMD Hedge Fund Activity: Q4 2020 in Review

77 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2020, worth a combined $221M — up 5.3% from $210M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of UTMD and 1 opened new positions — a net loss of 8 holders — while 29 trimmed existing stakes and 26 added.

The largest buyer was Vanguard Group, adding an estimated $1.27M. The largest seller was Natixis Advisors, exiting entirely with an estimated $1.08M sold.

  • 77 institutional investors held Utah Medical Products (UTMD) as of Q4 2020, down from 85 in Q3 2020.
  • Funds reported $221M of Utah Medical Products stock for Q4 2020, up 5.3% quarter-over-quarter.
  • 1 fund opened new Utah Medical Products positions in Q4 2020 and 9 closed out, a net change of -8 holders.
  • The largest Utah Medical Products buyer in Q4 2020 was Vanguard Group, an estimated $1.27M added.
  • The largest Utah Medical Products seller in Q4 2020 was Natixis Advisors, an estimated $1.08M sold.

Based on aggregated 13F filings for Q4 2020.